Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements "TREASURE"


Phase 2/3 Results N/A

Summary of Purpose

The primary objectives of this study is to evaluate the efficacy of HLCM051 on functional outcome in subjects with acute ischemic stroke and to evaluate the safety of HLCM051 in subjects with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 February 2018.

15 Nov 2017 7 Nov 2016 1 Mar 2020 1 Dec 2020 1 Feb 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

Not available